Screening mammography in women less than age 50 years

Current Opinion in Obstetrics and Gynecology

Volumn 24, Issue 1, 2012, Pages 38-43

  Kerlikowske, Karla ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

benefits and harms; digital mammography; risk based screening; screening mammography

Indexed keywords

AGE DISTRIBUTION; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; DIGITAL MAMMOGRAPHY; FAMILY HISTORY; HUMAN; MAMMOGRAPHY; PRIORITY JOURNAL; REVIEW;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84855768599     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0b013e32834da49a     Document Type: Review

References (45)

1. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2009; 59:27-41.
2. Feig SA, DOrsi CJ, Hendrick RE, et al. American College of Radiology guidelines for breast cancer screening. AJR Am J Roentgenol 1998; 171:29-33. (Pubitemid 28308644)
3. Breast Cancer Screening. Practice Bulletin 122. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011; 118:372-382.
4. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 151:716-726, W-236.
5. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151:727- 737; W237-W742.
6. Gotzsche P, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2006; CD001877.
7. Humphrey L, Helfand M, Chan B, Woolf S. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137:347-360. (Pubitemid 34977137)
8. Kerlikowske K. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit. Mongraph Natl Cancer Inst 1997; 22:79-86.
9. Miller A, Baines C, Wall C. The Canadian National Breast Screening Study-1: Breast cancer mortality after 11 to 16 years of follow-up. Ann Intern Med 2002; 137:305-312.
10. Ichikawa L, Barlow W, Anderson M, et al. Time trends in screening mammography performance from the community-based Breast Cancer Surveillance Consortium, 1996-2004. Radiology 2010; 256:74-82.
11. Ballard-Barbash R, Taplin SH, Yankaskas BC, et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. Am J Roentgenol 1997; 169:1001-1008. (Pubitemid 27406892)
12. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 2009; 151:738-747.
13. Farhat G, Walker R, Buist D, et al. Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use. J Clin Oncol 2010; 28:5140-5146.
14. Yankaskas BC, Haneuse S, Kapp JM, et al. Performance of first mammography examination in women younger than 40 years. J Natl Cancer Inst 2010; 102:692-701.
15. Hubbard R, Kerlikowske K, Flowers C, et al. Cumulative risk of false-positive recall or biopsy recommendation after 10 years of screening mammography. Ann Intern Med 2011; 155:481-492.
16. Barton M, Moore S, Polk S, et al. Increased patient concern after false-positive mammograms: clinician documentation and subsequent ambulatory visits. J Gen Intern Med 2001; 16:150-156. (Pubitemid 34208868)
17. Barton M, Morley D, Moore S, et al. Decreasing womens anxieties after abnormal mammograms: a controlled trial. J Natl Cancer Inst 2004; 96:529-538. (Pubitemid 38559577)
18. Lipkus I, Halabi S, Strigo T, Rimer B. The impact of abnormal mammograms on psychosocial outcomes and subsequent screening. Psychooncology 2000; 9:402-410.
19. Scaf-Klomp W, Sanderman R, van de Wiel H, et al. Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands. J Epidemiol Community Health 1997; 51:705-710. (Pubitemid 28014250)
20. Brett J, Bankhead C, Henderson B, et al. The psychological impact of mammographic screening. A systematic review. Psychooncology 2005; 14:917-938. (Pubitemid 41701209)
21. Weil J, Hawker J. Positive findings of mammography may lead to suicide. BMJ 1997; 314:754-755. (Pubitemid 27113094)
22. Woodward V, Webb C. Womens anxieties surrounding breast disorders: a systematic review of the literature. J Adv Nurs 2001; 33:29-41. (Pubitemid 33609376)
23. Brewer N, Salz T, Lillie S. Systematic review: the long-term effects of falsepositive mammograms. Ann Intern Med 2007; 146:502-510. (Pubitemid 351650559)
24. Yaffe M, Mainprize J. Risk of radiation-induced breast cancer from mammographic screening. Radiology 2011; 258:98-105.
25. De Gelder R, Draisma G, Heijnsdijk E, de Koning H. Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths. Br J Cancer 2011; 104:1214-1220.
26. Berrington de Gonzalez A, Reeves G. Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits. Br J Cancer 2005; 93:590-596. (Pubitemid 43080004)
27. De Gelder R, van As E, Tilanus-Linthorst M, et al. Breast cancer screening: evidence for false reassurance? Int J Cancer 2008; 123:680-686. (Pubitemid 351898428)
28. Armstrong K, Moye E, Williams S, et al. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 2007; 146:516-526. (Pubitemid 351650561)
29. De Koning H, Draisma G, Fracheboud J, de Bruijn A. Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data. Breast Cancer Res Treat 2006; 8:202.
30. Kumar A, Bhatia V, Henderson I. Overdiagnosis and overtreatment of breast cancer: rates of ductal carcinoma in situ: a US perspective. Breast Cancer Res 2005; 7:271-275. (Pubitemid 41830166)
31. Welch H. Screening mammography: a long run for a short slide? N Engl J Med 2010; 363:1276-1278.
32. De Gelder R, Heijnsdijk E, van Ravesteyn N, et al. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 2011; 33:111-121.
33. Ernster V, Ballard-Barbash R, Barlow W, et al. Detection of DCIS in women undergoing screening mammography. J Natl Cancer Inst 2002; 94:1546-1554. (Pubitemid 35277278)
34. Eusebi V, Feudale E, Foschini MP, et al. Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 1994; 11:223-235. (Pubitemid 24308083)
35. Kerlikowske K, Molinaro A, Cha I, et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst 2003; 95:1692-1702. (Pubitemid 37509078)
36. Page DL, Dupont WD, Rogers LW, et al. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995; 76:1197-1200.
37. Kerlikowske K, Molinaro A, Gauthier M, et al. Biomarker expression associated with increased risk of subsequent tumors after initial diagnosis of ductal carcinoma in situ. J Natl Cancer Inst 2010; 102:627-637.
38. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005; 353:1773-1783. (Pubitemid 41549889)
39. Kerlikowske K, Hubbard R, Miglioretti D, et al. Comparative-effectiveness of digital vs. film-screen mammography in community practice in the U.S. Ann Intern Med 2011; 155:493-502.
40. Tosteson AN, Stout NK, Fryback DG, et al. Cost-effectiveness of digital mammography breast cancer screening. Ann Intern Med 2008; 148: 1-10. (Pubitemid 351664941)
41. Tice JA, Cummings SR, Smith-Bindman R, et al. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 2008; 148:337-347. (Pubitemid 351665464)
42. Barlow WE, White E, Ballard-Barbash R, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 2006; 98:1204-1214. (Pubitemid 44390991)
43. Chen J, Pee D, Ayyagari R, et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 2006; 98:1215-1226. (Pubitemid 44390992)
44. Schousboe J, Kerlikowske K, Loh A, Cummings S. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med 2011; 155:10-20.
45. Lee JM, McMahon PM, Kong CY, et al. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology 2010; 254:793-800.